Ocuphire Pharma, Inc.·4

Jan 12, 5:33 PM ET

Hoffmann Bernhard 4

4 · Ocuphire Pharma, Inc. · Filed Jan 12, 2023

Insider Transaction Report

Form 4
Period: 2023-01-10
Hoffmann Bernhard
SVP of Corp. Dev.
Transactions
  • Award

    Common Stock

    2023-01-10+46,608146,728 total
  • Award

    Employee Stock Option (right to buy)

    2023-01-10+69,91269,912 total
    Exercise: $3.50Exp: 2033-01-09Common Stock (69,912 underlying)
Footnotes (2)
  • [F1]Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of January 10, 2023.
  • [F2]The option will vest with respect to 17,478 shares on January 10, 2024, with the balance vesting quarterly in twelve equal installments thereafter.

Documents

1 file
  • 4
    form4.xmlPrimary